RecruitingNCT06334003

Cardiometabolic Function in Offspring, Mother and Placenta After Assisted Reproductive Technology


Sponsor

Rigshospitalet, Denmark

Enrollment

600 participants

Start Date

May 17, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The overall objective is to establish the first-of-its-kind longitudinal cohort of pregnant women, biological fathers/partners and offspring from pregnancies achieved by frozen embryo transfer (FET), fresh-embryo transfer (fresh ET) and naturally conceived (NC) to investigate maternal cardiometabolic profiles, fetal growth patterns and placental function during pregnancy as well as metabolic and endocrine health in the offspring. Additionally, the aim is to explore genetic and epigenetic patterns in placenta, fetus and parents. As secondary objectives, the investigator group will examine telomere length and minipuberty hormones in children born after FET, fresh-ET and NC.


Eligibility

Min Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with art, cardiovascular disease other, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(3)

Fertility Clinic, Rigshospitalet, Copenhagen University Hospital

Copenhagen, Denmark

Department of Fetalmedicin, Herlev Hospital

Copenhagen, Denmark

Dept. of Paediatric and Adolescent Medicine, Herlev Hospital

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06334003


Related Trials